DULUTH, Ga.— Feb. 10, 2011 — Merial will continue the IVOMEC® (ivermectin) Spring Challenge for the fourth year based on the success of the program for cattle producers. Cattle prices are up, but so are production costs, and producers are feeling the strain on the profit outlook this year. To help promote greater profits and optimize herd health in 2011, Merial will help to take on some of the production risks. Producers will benefit from taking advantage of the IVOMEC Challenge with a risk-free way to ensure spring parasite control pays.
To participate, producers simply need to use any IVOMEC Brand Product on both their cows and calves in the spring. At weaning, if the improved 205-day adjusted weight versus the 2010 weight does not cover the purchase price of the IVOMEC Brand Product used in the spring, Merial will provide an equal number of doses of any IVOMEC Brand Product for fall.
“Merial recognizes that in a tight economy, it’s difficult to justify input costs if you aren’t sure you are getting enough return, but nothing pays off like parasite control in the spring,” says Frank Hurtig, DVM, MBA, director, Merial Large Animal Veterinary Services. “The goal is for producers to see a financial gain from their parasite control investment. Because we have confidence in our products, we are willing to back them so that if improvements aren’t achieved, producers won’t risk a profit loss on treatment expenses.”
When combined with good animal husbandry protocols, spring parasite treatments in cow/calf herds have been proven to increase weaning weights and reproductive performance.1-4 In fact, studies going back 25 years have shown a statistically significant increase in weaning weights when cows and calves were treated for parasites in the spring with IVOMEC Brand Products.1-3
“That gain alone will cover the cost of a using an IVOMEC Brand Product in the spring,” Dr. Hurtig says. “There are a lot of variables that can rob producers of production and profits. But between the proven results of spring parasite treatment and the promise of the IVOMEC Challenge, we are certain producers won’t lose money on this input.”
Iowa State University research results show that parasite control tops the list of the most economically rewarding cow/calf pharmaceutical practices. Not controlling parasites can negatively impact a cattle producer’s breakeven by up to $201 per head.5 Even if the return for the average herd is only $20, the impact is still significant when most producers see approximately a $105 income per cow.6
Regardless of all of the uncertainty in the cattle business, one thing remains true — cattle producers can trust all four proven formulations of IVOMEC Brand Products.
“Producers can’t afford to take chances with a health practice such as parasite control,” Dr. Hurtig says. “By choosing a product they can trust such as an IVOMEC Brand Product that is backed by a 100% Product Satisfaction Guarantee, producers can help protect both their cattle and pocketbook.”
For more information, producers should contact their local Merial sales representative or visit www.ivomec.com.
Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs approximately 5,600 people and operates in more than 150 countries worldwide. Its 2010 sales were $2.6 billion. Merial is the Animal Health subsidiary of sanofi-aventis.
For more information, please see www.merial.com.